Validity of the Systemic Lupus Erythematosus Disease Activity 2000-Glucocorticoid Index, its association with the Physician Global Assessment, and potential association with disease damage
Abstract Background The Systemic Lupus Erythematosus Disease Activity-2000 Glucocorticoid Index (SLEDAI-2 KG) accounts for glucocorticoids and possibly promising. The Physician Global Assessment (PGA) is subjective and debatable. Objectives Assessment of the validity of the SLEDAI-2 KG, its associat...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-01-01
|
| Series: | The Egyptian Journal of Internal Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43162-024-00389-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841544305697619968 |
|---|---|
| author | Basma M. Medhat Lobna A. Maged Doaa A. Teleb Sally S. Mohamed Angie Y. Afifi Dina M. T. Koptan Walaa Abdelrahman Dalia Dorgham Eman Hany Elsebaie Naglaa Afifi Sahar A. Ahmed Mervat E. Behairy Hala Ramadan |
| author_facet | Basma M. Medhat Lobna A. Maged Doaa A. Teleb Sally S. Mohamed Angie Y. Afifi Dina M. T. Koptan Walaa Abdelrahman Dalia Dorgham Eman Hany Elsebaie Naglaa Afifi Sahar A. Ahmed Mervat E. Behairy Hala Ramadan |
| author_sort | Basma M. Medhat |
| collection | DOAJ |
| description | Abstract Background The Systemic Lupus Erythematosus Disease Activity-2000 Glucocorticoid Index (SLEDAI-2 KG) accounts for glucocorticoids and possibly promising. The Physician Global Assessment (PGA) is subjective and debatable. Objectives Assessment of the validity of the SLEDAI-2 KG, its association with the PGA, and their potential association with the disease damage. Methods A cross-sectional study included SLE patients managed at 2 tertiary centers in Egypt were conducted. The SLEDAI-2 K was the gold standard score for assessment the disease activity. The SLEDAI-2 KG incorporates glucocorticoids’ dosage through an ordinal weight. The PGA (scale: 0–3) was categorized according to the PGA international standardization consensus in SLE study (PISCOS). Results The study included 608 patients [546 (89.8%) females and [62 (10.2%) males; age at onset: 27.5 ± 8.5 years; age at assessment: 31.4 ± 9.4 years; disease duration: 6.1 ± 5.5 years for females]. The mean SLEDAI-2 K, SLEDAI-2 KG, and PGA was 11.9 ± 9.3, 16 ± 10.5, and 1.2 ± 0.8, respectively. The correlation between both the SLEDAI-2 KG (r: 0.96, p < 0.001) and PGA (r: 0.5, p < 0.001) and SLEDAI-2 K was statistically significant. The association’s strength between both the SLEDAI-2 KG and PGA and SLEDAI-2 K declined among low activity-patients (SLEDAI-2 K < 6) [(r = 0,4; p < 0.001) (r = 0.2; p = 0.02), respectively], and the SLEDAI-2 KG and PGA were not associated in this subgroup (r: 0.07, p = 0.4). The agreement’s strength between the SLEDAI-2 K and PISCOS-PGA was weak (kappa = 0.17, p < 0.001). The SLEDAI-2 K and SLEDAI-2 KG were comparable predictors for damage and the PGA was a weaker predictor. Conclusion The SLEDAI-2 KG and PGA correlated significantly with the SLEDAI-2 K, yet the correlation’s strength declined among low disease activity-patients. The SLEDAI-2 K and SLEDAI-2 KG were comparable predictors for damage. |
| format | Article |
| id | doaj-art-ab205cb6d093485dab070e64fbd0cb86 |
| institution | Kabale University |
| issn | 2090-9098 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | The Egyptian Journal of Internal Medicine |
| spelling | doaj-art-ab205cb6d093485dab070e64fbd0cb862025-01-12T12:40:34ZengSpringerOpenThe Egyptian Journal of Internal Medicine2090-90982025-01-013711710.1186/s43162-024-00389-3Validity of the Systemic Lupus Erythematosus Disease Activity 2000-Glucocorticoid Index, its association with the Physician Global Assessment, and potential association with disease damageBasma M. Medhat0Lobna A. Maged1Doaa A. Teleb2Sally S. Mohamed3Angie Y. Afifi4Dina M. T. Koptan5Walaa Abdelrahman6Dalia Dorgham7Eman Hany Elsebaie8Naglaa Afifi9Sahar A. Ahmed10Mervat E. Behairy11Hala Ramadan12Cairo UniversityCairo UniversityCairo UniversityCairo UniversityCairo UniversityCairo UniversityCairo UniversityCairo UniversityCairo UniversityAin Shams UniversityCairo UniversityCairo UniversityCairo UniversityAbstract Background The Systemic Lupus Erythematosus Disease Activity-2000 Glucocorticoid Index (SLEDAI-2 KG) accounts for glucocorticoids and possibly promising. The Physician Global Assessment (PGA) is subjective and debatable. Objectives Assessment of the validity of the SLEDAI-2 KG, its association with the PGA, and their potential association with the disease damage. Methods A cross-sectional study included SLE patients managed at 2 tertiary centers in Egypt were conducted. The SLEDAI-2 K was the gold standard score for assessment the disease activity. The SLEDAI-2 KG incorporates glucocorticoids’ dosage through an ordinal weight. The PGA (scale: 0–3) was categorized according to the PGA international standardization consensus in SLE study (PISCOS). Results The study included 608 patients [546 (89.8%) females and [62 (10.2%) males; age at onset: 27.5 ± 8.5 years; age at assessment: 31.4 ± 9.4 years; disease duration: 6.1 ± 5.5 years for females]. The mean SLEDAI-2 K, SLEDAI-2 KG, and PGA was 11.9 ± 9.3, 16 ± 10.5, and 1.2 ± 0.8, respectively. The correlation between both the SLEDAI-2 KG (r: 0.96, p < 0.001) and PGA (r: 0.5, p < 0.001) and SLEDAI-2 K was statistically significant. The association’s strength between both the SLEDAI-2 KG and PGA and SLEDAI-2 K declined among low activity-patients (SLEDAI-2 K < 6) [(r = 0,4; p < 0.001) (r = 0.2; p = 0.02), respectively], and the SLEDAI-2 KG and PGA were not associated in this subgroup (r: 0.07, p = 0.4). The agreement’s strength between the SLEDAI-2 K and PISCOS-PGA was weak (kappa = 0.17, p < 0.001). The SLEDAI-2 K and SLEDAI-2 KG were comparable predictors for damage and the PGA was a weaker predictor. Conclusion The SLEDAI-2 KG and PGA correlated significantly with the SLEDAI-2 K, yet the correlation’s strength declined among low disease activity-patients. The SLEDAI-2 K and SLEDAI-2 KG were comparable predictors for damage.https://doi.org/10.1186/s43162-024-00389-3Systemic lupus erythematosusSLEDAI-2 KGlucocorticoidPhysician Global AssessmentDisease ActivityDisease Damage |
| spellingShingle | Basma M. Medhat Lobna A. Maged Doaa A. Teleb Sally S. Mohamed Angie Y. Afifi Dina M. T. Koptan Walaa Abdelrahman Dalia Dorgham Eman Hany Elsebaie Naglaa Afifi Sahar A. Ahmed Mervat E. Behairy Hala Ramadan Validity of the Systemic Lupus Erythematosus Disease Activity 2000-Glucocorticoid Index, its association with the Physician Global Assessment, and potential association with disease damage The Egyptian Journal of Internal Medicine Systemic lupus erythematosus SLEDAI-2 K Glucocorticoid Physician Global Assessment Disease Activity Disease Damage |
| title | Validity of the Systemic Lupus Erythematosus Disease Activity 2000-Glucocorticoid Index, its association with the Physician Global Assessment, and potential association with disease damage |
| title_full | Validity of the Systemic Lupus Erythematosus Disease Activity 2000-Glucocorticoid Index, its association with the Physician Global Assessment, and potential association with disease damage |
| title_fullStr | Validity of the Systemic Lupus Erythematosus Disease Activity 2000-Glucocorticoid Index, its association with the Physician Global Assessment, and potential association with disease damage |
| title_full_unstemmed | Validity of the Systemic Lupus Erythematosus Disease Activity 2000-Glucocorticoid Index, its association with the Physician Global Assessment, and potential association with disease damage |
| title_short | Validity of the Systemic Lupus Erythematosus Disease Activity 2000-Glucocorticoid Index, its association with the Physician Global Assessment, and potential association with disease damage |
| title_sort | validity of the systemic lupus erythematosus disease activity 2000 glucocorticoid index its association with the physician global assessment and potential association with disease damage |
| topic | Systemic lupus erythematosus SLEDAI-2 K Glucocorticoid Physician Global Assessment Disease Activity Disease Damage |
| url | https://doi.org/10.1186/s43162-024-00389-3 |
| work_keys_str_mv | AT basmammedhat validityofthesystemiclupuserythematosusdiseaseactivity2000glucocorticoidindexitsassociationwiththephysicianglobalassessmentandpotentialassociationwithdiseasedamage AT lobnaamaged validityofthesystemiclupuserythematosusdiseaseactivity2000glucocorticoidindexitsassociationwiththephysicianglobalassessmentandpotentialassociationwithdiseasedamage AT doaaateleb validityofthesystemiclupuserythematosusdiseaseactivity2000glucocorticoidindexitsassociationwiththephysicianglobalassessmentandpotentialassociationwithdiseasedamage AT sallysmohamed validityofthesystemiclupuserythematosusdiseaseactivity2000glucocorticoidindexitsassociationwiththephysicianglobalassessmentandpotentialassociationwithdiseasedamage AT angieyafifi validityofthesystemiclupuserythematosusdiseaseactivity2000glucocorticoidindexitsassociationwiththephysicianglobalassessmentandpotentialassociationwithdiseasedamage AT dinamtkoptan validityofthesystemiclupuserythematosusdiseaseactivity2000glucocorticoidindexitsassociationwiththephysicianglobalassessmentandpotentialassociationwithdiseasedamage AT walaaabdelrahman validityofthesystemiclupuserythematosusdiseaseactivity2000glucocorticoidindexitsassociationwiththephysicianglobalassessmentandpotentialassociationwithdiseasedamage AT daliadorgham validityofthesystemiclupuserythematosusdiseaseactivity2000glucocorticoidindexitsassociationwiththephysicianglobalassessmentandpotentialassociationwithdiseasedamage AT emanhanyelsebaie validityofthesystemiclupuserythematosusdiseaseactivity2000glucocorticoidindexitsassociationwiththephysicianglobalassessmentandpotentialassociationwithdiseasedamage AT naglaaafifi validityofthesystemiclupuserythematosusdiseaseactivity2000glucocorticoidindexitsassociationwiththephysicianglobalassessmentandpotentialassociationwithdiseasedamage AT saharaahmed validityofthesystemiclupuserythematosusdiseaseactivity2000glucocorticoidindexitsassociationwiththephysicianglobalassessmentandpotentialassociationwithdiseasedamage AT mervatebehairy validityofthesystemiclupuserythematosusdiseaseactivity2000glucocorticoidindexitsassociationwiththephysicianglobalassessmentandpotentialassociationwithdiseasedamage AT halaramadan validityofthesystemiclupuserythematosusdiseaseactivity2000glucocorticoidindexitsassociationwiththephysicianglobalassessmentandpotentialassociationwithdiseasedamage |